Key statistics
On Monday, Marinus Pharmaceuticals (MRNS*:MEX) closed at 124.00, 0.00% above its 52-week low of 124.00, set on Apr 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 124.00 |
Low | 124.00 |
Bid | -- |
Offer | -- |
Previous close | 124.00 |
Average volume | -- |
---|---|
Shares outstanding | 55.08m |
Free float | 54.56m |
P/E (TTM) | -- |
Market cap | 91.44m USD |
EPS (TTM) | -2.66 USD |
Data delayed at least 20 minutes, as of Apr 15 2024 19:39 BST.
More ▼
Press releases
- Marinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst Day
- Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024
- Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference
- Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024
- Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results
- Ligand Reports Second Quarter 2024 Financial Results
- Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2024 Financial Results on August 13, 2024
- Marinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated with CDKL5 Deficiency Disorder
More ▼